Welcome to our dedicated page for Spok Hldgs SEC filings (Ticker: SPOK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Spok Holdings, Inc. files SEC reports that document its healthcare communications business, Nasdaq-listed common stock, operating results, dividends and governance. Recent Form 8-K filings furnish quarterly and annual results, board dividend declarations, Regulation FD investor presentations and material corporate events related to executive roles and strategic realignment.
The company's proxy materials cover director elections, executive compensation, equity awards, shareholder voting matters and pay-versus-performance disclosure. Investor presentation exhibits and related filings describe risk areas for SPOK, including wireless network rationalization, paging-unit declines, dependence on the U.S. healthcare market, software sales cycles, competition, third-party vendors, product defects, security vulnerabilities and intellectual-property matters.
Spok Holdings (SPOK) Form 144 filing: Affiliate Calvin Rice intends to sell up to 14,736 common shares through Charles Schwab on or about 05 Aug 2025. At the reference price in the notice, the block is valued at roughly $270,552.
The planned disposition equals about 0.07 % of Spok’s 20.59 million shares outstanding and follows a separate sale of 7,457 shares on 04 Aug 2025 that generated $139,667. The shares being sold were recently acquired via restricted-stock-unit (RSU) vestings on 03 Mar 2025 (8,774 shares) and 03 Jan 2025 (5,962 shares).
Given the small size relative to the float and the compensatory origin of the shares, the filing suggests a routine insider liquidity event with negligible balance-sheet impact, though some investors may note the consecutive insider sales.
Form 144 summary for Spok Holdings, Inc. (SPOK)
The notice reports a proposed sale of 147,885 shares of common stock (par value $0.0001) through Goldman Sachs & Co. LLC with an aggregate market value of $2,737,351.35. The number of shares outstanding is reported as 20,590,924 and the approximate date of sale is 08/04/2025.
Acquisition details show the shares were purchased on 03/16/2023 in open-market transactions and paid in cash. The filing indicates no securities sold during the past three months by the reporting person in this notice.
Spok Holdings, Inc. (SPOK) – Form 144 filing
An insider has notified the SEC of an intent to sell up to 7,457 common shares, roughly 0.04 % of the 20.59 M shares outstanding. The shares, valued at about $139,667, were received through the vesting of restricted stock units on 01 Jan 2024. The planned sale is to be executed through Charles Schwab on or after 04 Aug 2025 on Nasdaq.
This Rule 144 notice does not itself complete the trade but signals a forthcoming disposition. No other insider sales were reported during the past three months, and the filer affirms possession of no undisclosed adverse information. Given the small size, the transaction is unlikely to affect liquidity or control, yet it may be watched by investors as a gauge of insider sentiment.
Spok Holdings (SPOK) – Form 144 insider sale notice.
Michael Wallace has filed to sell up to 10,000 SPOK common shares on or after 4 Aug 2025 via Charles Schwab. Based on the cited $18.36 reference price, the transaction is valued at roughly $183.6 k. The shares stem from a 16,306-share stock award received 1 Jan 2024. Wallace previously sold 6,000 shares for $99,137 on 7 May 2025. With 20.59 million shares outstanding, the proposed sale equals less than 0.05 % of the float and does not create dilution because no new shares are being issued.
Rule 144 requires the filer to certify that no undisclosed adverse information exists. While insider selling can signal caution, the modest size and planned, disclosed nature of this sale suggest minimal impact on liquidity or control. Investors may view it as routine portfolio diversification rather than a bearish signal.